Jiangsu Hansoh ADC HS-20093 holds potential to set new standard in SCLC second-line treatment in… EP News Bureau Nov 22, 2024 HS-20093: A breakthrough ADC poised to redefine second-line SCLC care in China, strengthening Jiangsu Hansoh's oncology leadership…
